- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Dr Stephen Grubbs: Value Conversation Will Go on for Years
The value discussion in healthcare is becoming more relevant as the healthcare system increases its focus on better outcomes, said Stephen Grubbs, MD, vice president for clinical affairs at the American Society for Clinical Oncology.
The value discussion in healthcare is becoming more relevant as the healthcare system increases its focus on better outcomes, said Stephen Grubbs, MD, vice president for clinical affairs at the American Society for Clinical Oncology.
Transcript (modified)
Why do we need the value discussion in healthcare, and specifically in oncology?
So the value definition, number 1, has to be clearly defined on what is value in medicine. The reason why we’re moving that way is because our healthcare system, and appropriately so, is beginning to move away from paying for doing things to beginning to say we really want to have better outcomes. So to begin to look at better outcomes we need to have a definition, then, of what is the value of a treatment to give you a better outcome.
I think the key point right now of the value discussion with ASCO is really for informed decision making by the patient, and that’s what we’re geared at right now. We'll evolve ... but this conversation's going to go on for years right now.
Impact of Amivantamab-Lazertinib on EGFR, MET Resistance Alterations in NSCLC: Danny Nguyen, MD
September 15th 2025The combination of amivantamab and lazertinib in first-line non–small cell lung cancer (NSCLC) significantly reduces resistance mechanisms with implications for second-line treatment, said Danny Nguyen, MD, of City of Hope.
Read More
Disparities in Biomarker Testing Impact Nonsquamous NSCLC Outcomes: Surbhi Singhal, MD
September 6th 2025Surbhi Singhal, MD, of the University of California Davis, discussed disparities in biomarker testing among patients diagnosed with stage IV nonsquamous non–small cell lung cancer (NSCLC).
Read More
